Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / INDXX GBL MED
-
Number of holders
-
7
-
Total shares
-
101K
-
Shares change
-
+22.4K
-
Total reported value, excl. options
-
$2.25M
-
Value change
-
+$499K
-
Number of buys
-
4
-
Number of sells
-
-1
-
Price
-
$22.26
Significant Holders of FIRST TR EXCHANGE-TRADED FD - INDXX GBL MED (MDEV) as of Q3 2024
filings reported holding MDEV - FIRST TR EXCHANGE-TRADED FD - INDXX GBL MED as of Q3 2024.
FIRST TR EXCHANGE-TRADED FD - INDXX GBL MED (MDEV) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 101K shares
.
Largest 8 shareholders include Glenview Trust co (36.9K shares), SRS Capital Advisors, Inc. (28K shares), JANE STREET GROUP, LLC (22.2K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.6K shares), OSAIC HOLDINGS, INC. (1.41K shares), HARBOUR INVESTMENTS, INC. (1.3K shares), UBS Group AG (786 shares), and BANK OF MONTREAL /CAN/ (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.